Topics

Companies Related to "Early rheumatoid arthritis characterised distinct transient synovial fluid" [Most Relevant Company Matches] - Page: 3 RSS

02:37 EST 26th February 2020 | BioPortfolio

Here are the most relevant search results for "Early rheumatoid arthritis characterised distinct transient synovial fluid" found in our extensive corporate database of over 50,000 company records.

Showing "Early rheumatoid arthritis characterised distinct transient synovial fluid" Companies 51–75 of 1,600+

Relevant

The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein ...


4SC AG

4SC AG (ISIN DE0005753818) is a drug discovery and development company focused on autoimmune and cancer indications. Vidofludimus (4SC-101), a small molecule, is currently in a Phase IIb study in rheumatoid arthritis and a Phase IIa exploratory study in inflammatory bowel disease. The company's lead oncology compound, resminostat (4SC-201), a pan histone d...

Regeneron Pharmaceuticals

Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of obesity, rheumatoid arthritis, and cancer. The Company also has preclinical programs in asthma, allergies, and other diseases and disorders. Regen...


Eiffel Technologies Limited

Eiffel's focus is on improving the performance and delivery of currently approved pharmaceuticals. The companies scientists have collectively 50 years experience in the modification and re-engineering of pharmaceutical compounds and are at the forefront of supercritical fluid research.Supercritical Fluid technologies can be used to produce uniform, very small drug particles. Drugs produced in this...

Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...

Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...

Amura Holdings Ltd

Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcore™, the bicyclic core molecular scaffold chemistry and the computational screening and design platform, ProtoDiscovery™. Amura has four NCE discovery programmes based on AMcore™:An Osteoporosis programme based on cathepsin K inhibitors, A Psoriasis programme based on a cathepsin S inhibit...

ISICR

The International Society for Interferon and Cytokine Research (ISICR), based in Bethesda, Md., is a non-profit organization devoted to interferon, cytokine and chemokine research in the fields of cell biology, molecular biology, biochemistry, and pre-clinical and clinical drug development. The ISICR provides a forum for sharing knowledge and encourages ...

Amber Pharmacy

Amber Pharmacy is an independent, family-owned pharmacy. For nearly 15 years, they have been providing comprehensive specialized services and medications for complex and chronic conditions including organ transplants, oncology, hepatitis, multiple sclerosis, rheumatoid arthritis, Crohn's disease, hemophilia, and all other complex and chronic conditions. Amber Pharmacy provides medication fulfillme...

Glatt Pharmaceutical Services

Glatt the pioneer of fluid bed technologyAfter establishing the company in 1954 in Binzen, by 1959 Werner Glatt, together with just a dozen employees, had designed and constructed the world's first fluid bed plant suitable for industrial application in the pharmaceutical industry. His credo and his success formula was "Satisfied customers". The company's main customer base lay in the solid process...

Denver Arthritis Clinic

The Denver Arthritis Clinic offers health care services in a beautiful outpatient setting. Conveniently located in the newly developed residential and business complex of Lowry just off 6th Avenue and Quebec Street. We are located on the ground floor with free parking and easy access.

Lycera Corporation

Lycera Corp. is focused on the discovery and development of selective, small-molecule immunomodulators for the treatment of patients with autoimmune diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Lycera is developing drug candidates that target two novel therapeutic pathways and have the potential for first-in-class oral ...

Regeneron Pharmaceuticals, Inc.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-re...

Pharmos Corporation

Pharmos discovers and develops novel therapeutics to treat a range of indications including specific diseases of the nervous system such as disorders of the brain-gut axis (IBS), pain/inflammation, and autoimmune disorders. The Company's lead product in development is Dextofisopam for the treatment of IBS which has been developed through Phase 2b clinical trials. The Company also has a proprietary...

BioClin Health Research, Inc.

BioClin Health Research, Inc. became incorporated in August of 2000, opening its first office in Richmond, British Columbia, Canada. BioClin is wholly owned by its founders Sandra and Jonathan Beard.Sandra Beard, RN, BSN, MSN, PhD (C) is President and Director of Clinical Operations. Ms. Beard brings over twenty years of clinical, educational, management and health services research experience to...

Chondrex, Inc

Chondrex, Inc. provides a variety of high quality reagents and consulting services for arthritis and inflammatory research, under the trade name Arthrogen-CIA®. We specialize in the biochemistry and immunology of collagen and collagen-related materials, as well as arthritis research models (authentic collagen-induced arthritis model and newly developed monoclonal antibody-induced arthritis model...

Nitec Pharma AG

Nitec Pharma is a Switzerland-based specialty pharmaceutical company focused on the development and commercialisation of innovative medicines and effective treatment solutions for chronic inflammation and pain-related diseases. Nitec's most advanced product is Lodotra(TM), a circadian cytokine modulator (CCM) for the treatment of rheumatoid arthritis (RA), which has received a recommendation f...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, inflammatory diseases, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based ass...

HemoCleanse, Inc.

HemoCleanse has an extensive history of research and product development of innovative medical technologies, particularly in sorbent-based extracorporeal therapies and vascular access systems for use with other extracorporeal therapies. Areas of focus have been and continue to be: Liver disease, including hepatitis Drug overdose Sepsis Autoimmune diseases, including lupus, rheumatoid arthritis, .....

Chondrex, Incorporated

Chondrex, Inc. provides a variety of high quality reagents and consulting services for arthritis and related research, under the trade name Arthrogen-CIA®. Chondrex specialize in the biochemistry and immunology of collagen and collagen-related materials, as well as arthritis research models (authentic collagen-induced arthritis model and newly developed monoclonal antibody-induced arthritis mode...

Cera Products Incorporated

Cera Products, Inc. was established in 1993 in Maryland and works with worldwide public health and medical experts to develop products that will help promote early recovery from diarrhea and prevent dehydration, a potentially serious consequence of illness with fluid losses. Cera Products, Inc. blends the best of nature with the latest scientific knowledge, and produces under Good Manufacturing Pr...

Cypress Bioscience, Inc.

Cypress Bioscience is a pharmaceutical company dedicated to the development of innovative drugs targeting large unmet medical needs for patients suffering from a variety of disorders of the central nervous system. Since 1999, Cypress has received FDA approvals for both of the products it brought to the FDA during that period, including for Prosorba™, ...

The Global Healthy Living Foundation

The Global Healthy Living Foundation is a 501(c)(3) non-profit organization whose mission is to improve the quality of life for people living with chronic illnesses by advocating for improved access to care at the community, state, and federal levels, and amplifying education and awareness efforts within its social media framework. The Global Healthy ...

Peptor

Peptor's mission is to become a leading developer of drugs for the specific treatment of autoimmune diseases. The company has targeted Diabetes, Rheumatoid Arthritis and other autoimmune diseases that lack curative treatment.Peptor's competitive edge is based on a proprietary technology platform which enables the manipulation of a key player in the immune system - Heat Shock Protein 60 (hsp60). Th...

Tiziana Life Sciences plc

Tiziana Life Sciences plc is a UK biotechnology company that focuses on the discovery and development of novel molecules that treat human disease in oncology and immunology. The Company is focused on its lead compound milciclib. The Company is also in clinical development of foralumab. Foralumab is the only fully human engineered anti-human CD3 antibody in...


More From BioPortfolio on "Early rheumatoid arthritis characterised distinct transient synovial fluid"

Quick Search

Corporate Database Quicklinks